News tagged with adverse drug reactions
New discovery could lead to new way to screen drugs for adverse reactions
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs. A groundbreaking finding by researchers from the La Jolla Institute for Allergy ...
Immunology
May 29, 2012 |
5 / 5 (3) |
0
|
Depression raises diabetics' risk of severe low blood sugar episodes
(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...
Psychology & Psychiatry
May 24, 2013 |
not rated yet |
0
|
Drugs without side effects: Researchers explore novel ways to classify proteins
Janelle Leuthaeuser is on the cutting edge of biophysics. A molecular genetics and genomics Ph.D. student, she is part of a nationwide effort to create a more efficient generation of protein-based drugs.
Medical research
Apr 26, 2013 |
5 / 5 (1) |
0
|
Profs aim to track drug reactions via social media
Experiencing nausea, headaches or other side effects from prescriptions or over-the-counter medicines? Researchers say tweeting about it or posting your concerns online could one day help alert drug companies and federal ...
Medications
Oct 03, 2012 |
not rated yet |
0
Taking a predictive approach to identifying adverse drug reactions
In a move aimed at bolstering current systems for assessing and monitoring drug safety, researchers at Children's Hospital Boston have created a new method that combines multiple forms of widely available data to predict ...
Medications
Dec 21, 2011 |
not rated yet |
0
|
Scientists discover how to design drugs that could target particular nerve cells
(Medical Xpress) -- The future of drug design lies in developing therapies that can target specific cellular processes without causing adverse reactions in other areas of the nervous system. Scientists at the Universities ...
Medical research
Nov 10, 2011 |
4.5 / 5 (2) |
0
|
ER visits tied to ambien on the rise
(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.
Medications
May 01, 2013 |
not rated yet |
0
Lymphoseek approved to help locate lymph nodes
(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.
Cancer
Mar 13, 2013 |
not rated yet |
0
Octaplas approved for blood-clotting disorders
(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.
Medications
Jan 17, 2013 |
not rated yet |
0
Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Medications
Dec 17, 2012 |
not rated yet |
0
Recent increase in adverse TMP-SMX reactions in children
(HealthDay)—There has been a significant increase in adverse drug reactions (ADRs) associated with use of trimethoprim-sulfamethoxazole (TMP-SMX) for treatment of skin and soft tissue infection (SSTI) in ...
Pediatrics
Dec 03, 2012 |
not rated yet |
0
Xeljanz approved for rheumatoid arthritis
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Arthritis & Rheumatism
Nov 07, 2012 |
not rated yet |
0
BMJ editor urges Roche to fulfil promise to release Tamiflu trial data
In an open letter to company director, Professor Sir John Bell, she says: "Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate ...
Medications
Oct 30, 2012 |
not rated yet |
0
Parent-clinician communication about children's drug reactions needs improvement
Many parents are dissatisfied with communication regarding adverse drug reactions experienced by their child, and the implications of such reactions for the child's future use of medicines, according to a new study published ...
Health
Oct 10, 2012 |
not rated yet |
0
Aubagio approved for multiple sclerosis
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
Medications
Sep 13, 2012 |
not rated yet |
0
